Logo image of DOC

HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:DOC - US42250P1030 - REIT

16.03 USD
+0.25 (+1.58%)
Last: 12/24/2025, 8:25:26 PM
16 USD
-0.03 (-0.19%)
After Hours: 12/24/2025, 8:25:26 PM
Fundamental Rating

3

Taking everything into account, DOC scores 3 out of 10 in our fundamental rating. DOC was compared to 128 industry peers in the Diversified REITs industry. There are concerns on the financial health of DOC while its profitability can be described as average. DOC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DOC had positive earnings in the past year.
DOC had a positive operating cash flow in the past year.
In the past 5 years DOC has always been profitable.
Each year in the past 5 years DOC had a positive operating cash flow.
DOC Yearly Net Income VS EBIT VS OCF VS FCFDOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

DOC has a Return On Assets of -0.20%. This is in the lower half of the industry: DOC underperforms 61.72% of its industry peers.
DOC's Return On Equity of -0.51% is on the low side compared to the rest of the industry. DOC is outperformed by 61.72% of its industry peers.
DOC's Return On Invested Capital of 2.23% is in line compared to the rest of the industry. DOC outperforms 41.41% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.05%.
The last Return On Invested Capital (2.23%) for DOC is above the 3 year average (2.19%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.2%
ROE -0.51%
ROIC 2.23%
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
DOC Yearly ROA, ROE, ROICDOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

DOC's Profit Margin has improved in the last couple of years.
The Operating Margin of DOC (18.19%) is comparable to the rest of the industry.
DOC's Operating Margin has declined in the last couple of years.
DOC's Gross Margin of 60.08% is on the low side compared to the rest of the industry. DOC is outperformed by 67.19% of its industry peers.
DOC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.19%
PM (TTM) N/A
GM 60.08%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
DOC Yearly Profit, Operating, Gross MarginsDOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DOC is destroying value.
Compared to 1 year ago, DOC has more shares outstanding
DOC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DOC has about the same debt to assets ratio.
DOC Yearly Shares OutstandingDOC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
DOC Yearly Total Debt VS Total AssetsDOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

DOC has an Altman-Z score of 0.28. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.28, DOC is doing worse than 62.50% of the companies in the same industry.
DOC has a debt to FCF ratio of 20.30. This is a negative value and a sign of low solvency as DOC would need 20.30 years to pay back of all of its debts.
DOC has a better Debt to FCF ratio (20.30) than 76.56% of its industry peers.
A Debt/Equity ratio of 1.20 is on the high side and indicates that DOC has dependencies on debt financing.
DOC has a Debt to Equity ratio (1.20) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 20.3
Altman-Z 0.28
ROIC/WACC0.36
WACC6.23%
DOC Yearly LT Debt VS Equity VS FCFDOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

DOC has a Current Ratio of 0.11. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
DOC has a Current ratio of 0.11. This is amonst the worse of the industry: DOC underperforms 96.09% of its industry peers.
A Quick Ratio of 0.11 indicates that DOC may have some problems paying its short term obligations.
With a Quick ratio value of 0.11, DOC is not doing good in the industry: 96.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
DOC Yearly Current Assets VS Current LiabilitesDOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The earnings per share for DOC have decreased strongly by -57.45% in the last year.
Measured over the past years, DOC shows a very strong growth in Earnings Per Share. The EPS has been growing by 28.47% on average per year.
DOC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.58%.
Measured over the past years, DOC shows a quite strong growth in Revenue. The Revenue has been growing by 16.84% on average per year.
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%

3.2 Future

The Earnings Per Share is expected to decrease by -0.97% on average over the next years.
Based on estimates for the next years, DOC will show a small growth in Revenue. The Revenue will grow by 4.64% on average per year.
EPS Next Y-34.04%
EPS Next 2Y-12.64%
EPS Next 3Y-7.02%
EPS Next 5Y-0.97%
Revenue Next Year3.67%
Revenue Next 2Y2.96%
Revenue Next 3Y3.48%
Revenue Next 5Y4.64%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DOC Yearly Revenue VS EstimatesDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
DOC Yearly EPS VS EstimatesDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 80.15, which means the current valuation is very expensive for DOC.
The rest of the industry has a similar Price/Earnings ratio as DOC.
The average S&P500 Price/Earnings ratio is at 26.59. DOC is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 60.02 indicates a quite expensive valuation of DOC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of DOC to the average of the S&P500 Index (24.03), we can say DOC is valued expensively.
Industry RankSector Rank
PE 80.15
Fwd PE 60.02
DOC Price Earnings VS Forward Price EarningsDOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DOC indicates a somewhat cheap valuation: DOC is cheaper than 67.19% of the companies listed in the same industry.
71.88% of the companies in the same industry are more expensive than DOC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.76
EV/EBITDA 12.77
DOC Per share dataDOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as DOC's earnings are expected to decrease with -7.02% in the coming years.
PEG (NY)N/A
PEG (5Y)2.81
EPS Next 2Y-12.64%
EPS Next 3Y-7.02%

5

5. Dividend

5.1 Amount

DOC has a Yearly Dividend Yield of 7.43%, which is a nice return.
DOC's Dividend Yield is a higher than the industry average which is at 6.33.
Compared to an average S&P500 Dividend Yield of 1.87, DOC pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.43%

5.2 History

The dividend of DOC decreases each year by -2.76%.
DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
DOC Yearly Dividends per shareDOC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DOC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The Dividend Rate of DOC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-2176.08%
EPS Next 2Y-12.64%
EPS Next 3Y-7.02%
DOC Yearly Income VS Free CF VS DividendDOC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

HEALTHPEAK PROPERTIES INC

NYSE:DOC (12/24/2025, 8:25:26 PM)

After market: 16 -0.03 (-0.19%)

16.03

+0.25 (+1.58%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-23 2025-10-23/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners97.34%
Inst Owner Change5.77%
Ins Owners0.22%
Ins Owner Change0.78%
Market Cap11.14B
Revenue(TTM)2.80B
Net Income(TTM)-38.93M
Analysts77.5
Price TargetN/A
Short Float %3.11%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield 7.43%
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP-2176.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-19 2025-12-19 (0.10167)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.17%
Min EPS beat(2)-19.41%
Max EPS beat(2)37.75%
EPS beat(4)2
Avg EPS beat(4)-12.11%
Min EPS beat(4)-79.16%
Max EPS beat(4)37.75%
EPS beat(8)5
Avg EPS beat(8)12.39%
EPS beat(12)7
Avg EPS beat(12)15.73%
EPS beat(16)10
Avg EPS beat(16)43.13%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)0.74%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)8
Avg Revenue beat(12)-4.75%
Revenue beat(16)11
Avg Revenue beat(16)-3.38%
PT rev (1m)-1.36%
PT rev (3m)-2.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.08%
EPS NY rev (1m)2.15%
EPS NY rev (3m)-8.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 80.15
Fwd PE 60.02
P/S 3.98
P/FCF 24.76
P/OCF 8.98
P/B 1.47
P/tB 1.59
EV/EBITDA 12.77
EPS(TTM)0.2
EY1.25%
EPS(NY)0.27
Fwd EY1.67%
FCF(TTM)0.65
FCFY4.04%
OCF(TTM)1.79
OCFY11.14%
SpS4.03
BVpS10.93
TBVpS10.05
PEG (NY)N/A
PEG (5Y)2.81
Graham Number7.01
Profitability
Industry RankSector Rank
ROA -0.2%
ROE -0.51%
ROCE 2.83%
ROIC 2.23%
ROICexc 2.25%
ROICexgc 2.46%
OM 18.19%
PM (TTM) N/A
GM 60.08%
FCFM 16.06%
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexgc growth 3Y3.4%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 20.3
Debt/EBITDA 5.78
Cap/Depr 73.87%
Cap/Sales 28.24%
Interest Coverage 1.93
Cash Conversion 78.53%
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z 0.28
F-Score4
WACC6.23%
ROIC/WACC0.36
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
EPS Next Y-34.04%
EPS Next 2Y-12.64%
EPS Next 3Y-7.02%
EPS Next 5Y-0.97%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
Revenue Next Year3.67%
Revenue Next 2Y2.96%
Revenue Next 3Y3.48%
Revenue Next 5Y4.64%
EBIT growth 1Y-12.91%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year229.52%
EBIT Next 3Y52.42%
EBIT Next 5Y31.86%
FCF growth 1Y542.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.14%
OCF growth 3Y10.42%
OCF growth 5Y4.82%

HEALTHPEAK PROPERTIES INC / DOC FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to DOC.


Can you provide the valuation status for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.


What is the profitability of DOC stock?

HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 4 / 10.


Can you provide the financial health for DOC stock?

The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 1 / 10.


Can you provide the dividend sustainability for DOC stock?

The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is -2176.08%.